Salient Capital Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-10,590
Closed -$768K 60
2017
Q2
$768K Buy
10,590
+30
+0.3% +$2.02K 0.02% 131
2017
Q1
$688K Sell
10,560
-3,175
-23% -$200K 0.01% 157
2016
Q4
$860K Sell
13,735
-513
-4% -$31.3K 0.02% 132
2016
Q3
$899K Buy
14,248
+443
+3% +$28.7K 0.02% 122
2016
Q2
$855K Sell
13,805
-456
-3% -$27.8K 0.02% 132
2016
Q1
$815K Sell
14,261
-10,599
-43% -$591K 0.02% 134
2015
Q4
$1.47M Sell
24,860
-19,842
-44% -$1.14M 0.04% 101
2015
Q3
$2.43M Sell
44,702
-6,757
-13% -$440K 0.06% 91
2015
Q2
$3.46M Sell
51,459
-5,503
-10% -$359K 0.06% 92
2015
Q1
$3.33M Sell
56,962
-8,763
-13% -$529K 0.06% 88
2014
Q4
$4.3M Sell
65,725
-2,228
-3% -$140K 0.09% 82
2014
Q3
$3.92M Buy
67,953
+9,396
+16% +$522K 0.07% 92
2014
Q2
$3.31M Sell
58,557
-6,618
-10% -$347K 0.07% 86
2014
Q1
$3.35M Buy
65,175
+21,115
+48% +$1.07M 0.09% 74
2013
Q4
$2.33M Buy
44,060
+13,095
+42% +$644K 0.07% 86
2013
Q3
$1.39M Buy
30,965
+2,051
+7% +$90.9K 0.06% 92
2013
Q2
$1.2M Buy
+28,914
New +$1.26M 0.05% 91

Other funds holding ABBV